StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
213
This month
2
This week
1
This year
26
Publishing Date
2024 - 03 - 11
2
2024 - 02 - 14
2
2024 - 02 - 12
2
2024 - 01 - 30
2
2024 - 01 - 22
2
2023 - 08 - 30
2
2023 - 07 - 10
2
2023 - 04 - 13
2
2022 - 12 - 30
2
2022 - 12 - 06
3
2022 - 11 - 28
2
2022 - 11 - 02
2
2022 - 10 - 14
2
2022 - 09 - 26
3
2022 - 09 - 19
2
2022 - 08 - 05
2
2022 - 06 - 17
3
2022 - 06 - 03
2
2022 - 05 - 17
2
2022 - 04 - 26
3
2022 - 03 - 22
2
2022 - 02 - 22
2
2021 - 11 - 24
1
2021 - 11 - 12
1
2021 - 10 - 29
1
2021 - 10 - 13
1
2021 - 10 - 07
1
2021 - 10 - 06
2
2021 - 10 - 04
2
2021 - 09 - 17
1
2021 - 09 - 01
1
2021 - 08 - 31
1
2021 - 08 - 23
1
2021 - 08 - 17
1
2021 - 08 - 13
1
2021 - 08 - 06
2
2021 - 08 - 05
3
2021 - 07 - 30
1
2021 - 07 - 07
1
2021 - 07 - 05
1
2021 - 07 - 01
1
2021 - 06 - 24
1
2021 - 06 - 18
2
2021 - 06 - 16
1
2021 - 06 - 15
1
2021 - 06 - 14
1
2021 - 06 - 11
1
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 14
1
2021 - 04 - 30
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 15
1
2021 - 04 - 14
1
2021 - 03 - 31
1
2021 - 03 - 11
1
2021 - 03 - 04
1
Sector
Commercial services
2
Communications
2
Consumer non-durables
5
Distribution services
1
Electronic technology
1
Health services
3
Health technology
213
Manufacturing
35
Mining, quarrying, and oil and gas extraction
1
N/a
20
Process industries
4
Producer manufacturing
3
Professional, scientific, and technical services
2
Tags
Abbvie
3
Active
2
America
12
Antibiotics
3
Antibody
4
Approval
2
Astrazeneca
4
Biosimilar
2
Biotech
4
Breast
3
Business
2
Cancer
28
Cel
2
Clinical-trials-phase-iii
2
Covid
5
Covid-19
4
Depression
2
Diabetes
11
Diagnostic
2
Diagnostics
3
Disease
18
Drug
30
Drug delivery
4
Expansion
2
Expected
7
Global
54
Growing
16
Growth
70
Health
3
Immunotherapy
4
Impact
2
Infection
2
Infections
3
Influenza
5
Injection
3
Insulin
2
Iot
2
Key
3
Kidney
3
Liver
4
Lung
3
Market
139
Mobile
2
N/a
207
Patent
5
Pharma
9
Protein
3
Reach
7
Report
45
Research
26
Respiratory
3
Sanofi
6
Set
7
Stroke
3
System
4
Therapeutics
36
Therapy
6
Travel
6
Treatment
13
Vaccine
28
Entities
Abbott laboratories
250
Abbvie inc.
211
Alnylam pharmaceuticals, inc.
78
Alphabet inc.
31
Amarin corporation plc
30
Amgen inc.
170
Astellas pharma inc
70
Astrazeneca plc
213
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
30
Baxter international inc.
45
Becton, dickinson and company
34
Biogen inc.
53
Biomarin pharmaceutical inc.
29
Biontech se
167
Blueprint medicines corporation
20
Boston scientific corporation
25
Bristol-myers squibb company
119
Byline bancorp, inc.
26
Clovis oncology, inc.
20
Csl ltd
22
Denali therapeutics inc.
22
Eli lilly and company
335
Endo international plc
20
Galapagos nv
35
Gilead sciences, inc.
64
Glaxosmithkline plc
334
Igm biosciences, inc.
37
Incyte corporation
121
Innate pharma s.a.
109
Innate pharma sa
81
Johnson & johnson
567
Karyopharm therapeutics inc.
25
Kymera therapeutics, inc.
29
Ligand pharmaceuticals incorporated
20
Medtronic plc
45
Mobiv acquisition corp
65
Moderna, inc.
34
Morphosys ag
35
Nektar therapeutics
42
Novartis ag
329
Novo nordisk a/s
139
Oncocyte corporation
31
Orange
49
Perrigo company
110
Pfizer, inc.
153
Provention bio, inc.
283
Ptc therapeutics, inc.
31
Rallybio corp
30
Rcf acquisition corp.
83
Regeneron pharmaceuticals, inc.
254
Sanofi
4534
Takeda pharmaceutical company limited
60
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
30
Thermo fisher scientific inc
43
Translate bio, inc.
21
Vaxart, inc.
32
Viatris inc.
87
Vir biotechnology, inc.
22
Symbols
ABBV
100
ABT
82
ALKS
5
ALPMF
42
ALPMY
42
AMGN
106
ARTL
17
ATR
6
ATXI
7
AVEO
6
AZN
664
AZNCF
447
BAX
27
BDX
7
BHC
12
BIIB
22
BMY
61
BNTX
8
BSX
5
CGEN
7
CKPT
5
CMXHF
14
CSLLY
14
DERM
6
ENDP
9
ENDPQ
6
FBIO
31
GILD
10
GLAXF
156
GLPG
8
GLPGF
8
GNPX
9
GSK
189
HCM
11
ILMN
7
JAZZ
5
JNJ
117
LLY
97
MBIO
6
MDT
14
MMM
13
MRNA
5
MTLHF
5
MTLHY
5
NBIX
5
NVO
29
NVS
198
NVSEF
171
PBYI
6
PFE
45
PHG
11
RBGLY
5
RBGPF
5
SNY
213
SNYNF
176
TAK
29
TEVA
7
TEVJF
85
TMO
19
VTRS
32
Exchanges
Amex
3
Nasdaq
213
Nyse
201
Crawled Date
2024 - 03 - 11
2
2024 - 03 - 08
2
2024 - 02 - 14
2
2024 - 02 - 12
2
2024 - 02 - 07
2
2024 - 01 - 30
2
2024 - 01 - 22
2
2023 - 08 - 30
2
2023 - 07 - 10
2
2023 - 04 - 28
2
2023 - 04 - 13
2
2022 - 12 - 30
2
2022 - 12 - 06
3
2022 - 11 - 02
2
2022 - 10 - 14
2
2022 - 09 - 26
3
2022 - 09 - 19
2
2022 - 08 - 05
2
2022 - 06 - 17
3
2022 - 06 - 03
2
2022 - 05 - 17
2
2022 - 04 - 26
3
2022 - 03 - 22
2
2022 - 02 - 22
2
2021 - 10 - 29
1
2021 - 10 - 13
1
2021 - 10 - 07
1
2021 - 10 - 06
2
2021 - 10 - 04
2
2021 - 09 - 17
1
2021 - 09 - 01
1
2021 - 08 - 31
1
2021 - 08 - 23
1
2021 - 08 - 17
1
2021 - 08 - 13
1
2021 - 08 - 06
2
2021 - 08 - 05
3
2021 - 07 - 30
1
2021 - 07 - 07
1
2021 - 07 - 05
1
2021 - 07 - 01
1
2021 - 06 - 24
1
2021 - 06 - 18
2
2021 - 06 - 16
1
2021 - 06 - 15
1
2021 - 06 - 14
1
2021 - 06 - 11
1
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 05
1
2021 - 06 - 01
1
2021 - 05 - 14
1
2021 - 04 - 30
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 15
1
2021 - 04 - 14
1
2021 - 03 - 31
1
2021 - 03 - 11
1
2021 - 03 - 04
1
Crawled Time
00:00
9
00:20
3
01:00
7
02:00
6
04:00
8
04:20
3
05:00
5
06:00
4
07:00
6
08:00
6
09:00
9
10:00
8
11:00
9
12:00
7
12:20
1
12:30
1
13:00
5
13:02
1
13:15
2
13:20
2
13:30
1
14:00
6
14:15
1
14:30
1
15:00
9
15:15
1
15:20
3
15:30
3
16:00
13
16:20
1
17:00
9
18:00
12
19:00
15
20:00
11
21:00
6
22:00
7
23:00
12
Source
www.biospace.com
6
www.globenewswire.com
2
www.prnewswire.com
205
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Astrazeneca plc
symbols :
SNY
save search
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
-0.47%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$39.65
0.33%
-1.19%
2.3M
|
Health Technology
|
-0.85%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
2.16%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-2.9%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
S
|
$90.07
-0.44%
-0.43%
780K
|
Health Technology
|
-0.46%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
-0.68%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-0.22%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
1.57%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
$11.12
0.18%
0.09%
2.3M
|
Health Technology
|
-5.76%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-2.83%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-5.88%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.6
-0.69%
0.0%
2.2M
|
Health Technology
|
-16.04%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-1.64%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-3.02%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
1.21%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
0.45%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-8.42%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$105.27
-0.6%
-0.38%
5.9M
|
Health Technology
|
-5.06%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-8.47%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
0.01%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
1.45%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-9.19%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-7.74%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
2.23%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-8.02%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-5.84%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
0.88%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published:
2024-03-11
(Crawled : 14:30)
- prnewswire.com
CMXHF
|
$172.54
-1.41%
-19.21%
140
|
n/a
|
-5.41%
|
O:
0.41%
H:
0.0%
C:
0.0%
CSLLY
|
$86.918
-1.19%
3.3%
60K
|
n/a
|
-6.8%
|
O:
-4.92%
H:
3.76%
C:
3.44%
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-5.92%
|
O:
-3.4%
H:
1.49%
C:
1.49%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
3.19%
|
O:
1.55%
H:
0.82%
C:
0.16%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-12.05%
|
O:
-1.41%
H:
5.06%
C:
4.01%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-8.21%
|
O:
-0.6%
H:
0.19%
C:
0.09%
ABT
|
News
|
$105.27
-0.6%
-0.38%
5.9M
|
Health Technology
|
-11.91%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-5.31%
|
O:
0.57%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
2.65%
|
O:
1.08%
H:
0.82%
C:
0.67%
pharma
vaccine
astrazeneca
research
key
market
US Healthcare Advertising Market Analysis Report 2024-2032: A $23.5 Billion Industry in 2023 with Insights on Major Players' Sales and Advertising Spend
Published:
2024-03-09
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
sales
report
market
Global Dyslipidemia Drugs Market Set to Reach $30.98 Billion by 2034 with Statins Dominating and PCSK9 Inhibitors Showing Rapid Growth
Published:
2024-03-08
(Crawled : 18:00)
- prnewswire.com
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
4.68%
|
O:
3.21%
H:
0.0%
C:
-1.71%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-9.42%
|
O:
-0.68%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-5.38%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
3.13%
|
O:
-0.03%
H:
0.62%
C:
0.5%
rapid
reach
global
set
growth
market
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
4.68%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-6.85%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-9.42%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
-3.77%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$105.27
-0.6%
-0.38%
5.9M
|
Health Technology
|
-11.4%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-5.38%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
3.13%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-2.9%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Cervical Cancer Global Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
Published:
2024-03-01
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.32%
|
O:
0.01%
H:
0.0%
C:
-0.43%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
6.85%
|
O:
0.59%
H:
2.06%
C:
2.06%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-5.17%
|
O:
-1.27%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
6.4%
|
O:
0.28%
H:
0.75%
C:
0.4%
review
cancer
trials
global
trial
Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published:
2024-02-27
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
4.09%
|
O:
-1.72%
H:
2.54%
C:
2.54%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
-2.74%
|
O:
-2.2%
H:
2.39%
C:
1.34%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-6.76%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
3.54%
|
O:
0.01%
H:
0.79%
C:
0.6%
report
agonist
global
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-0.62%
-4.38%
7.2K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$563.5
-2.68%
-19.1%
6
|
Health Technology
|
12.7%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.65
-2.88%
0.02%
32K
|
Professional, Scientific, and T...
|
15.41%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$541.52
-1.05%
-0.1%
1.8M
|
Health Technology
|
-1.04%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-8.3%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-8.08%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.65
0.33%
-1.19%
2.3M
|
Health Technology
|
0.2%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-5.33%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.38%
5.9M
|
Health Technology
|
-5.49%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
$28.91
-1.06%
-1.11%
130K
|
Health Technology
|
-25.19%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$190.52
-0.85%
-0.84%
1.3M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
News
|
$393.48
0.1%
0.1%
780K
|
Health Technology
|
-5.07%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$190.52
-0.85%
-0.84%
1.3M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
News
|
$14.22
3.64%
3.38%
690K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$393.48
0.1%
0.1%
780K
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-2.49%
-0.42%
11K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.82
0.19%
0.19%
1.5M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$190.52
-0.85%
-0.84%
1.3M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$358.41
-2.13%
-2.11%
220K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
9.56%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-7.87%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
1.43%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-3.03%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-5.62%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$105.27
-0.6%
-0.38%
5.9M
|
Health Technology
|
-5.21%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-2.34%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
9.65%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-8.99%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-12.38%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
8.24%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-9.35%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-12.95%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-7.8%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-8.17%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-5.31%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-1.26%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
7.47%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published:
2024-02-07
(Crawled : 08:00)
- prnewswire.com
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-5.15%
|
O:
0.43%
H:
0.67%
C:
0.21%
BAX
|
$39.65
0.33%
-1.19%
2.3M
|
Health Technology
|
-0.03%
|
O:
0.21%
H:
0.24%
C:
-1.04%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
BMRN
S
|
$90.07
-0.44%
-0.43%
780K
|
Health Technology
|
1.44%
|
O:
-0.38%
H:
1.79%
C:
0.22%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
america
therapeutics
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-0.62%
-4.38%
7.2K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-6.93%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-1.95%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$393.48
0.1%
0.1%
780K
|
Health Technology
|
-5.09%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.27
2.03%
2.01%
560K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published:
2024-01-30
(Crawled : 23:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-16.94%
|
O:
4.34%
H:
0.0%
C:
0.0%
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
3.09%
|
O:
3.41%
H:
0.0%
C:
-2.45%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-19.27%
|
O:
0.0%
H:
1.38%
C:
0.26%
VTRS
|
$11.12
0.18%
0.09%
2.3M
|
Health Technology
|
-5.84%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-13.61%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
1.3%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
0.15%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-9.47%
|
O:
1.75%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
1.58%
|
O:
0.82%
H:
0.12%
C:
-1.64%
market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
3.09%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
|
$11.12
0.18%
0.09%
2.3M
|
Health Technology
|
-5.84%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-13.61%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
1.3%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
0.15%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-9.47%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$4.99
-3.48%
-3.82%
290K
|
Health Technology
|
8.5%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
1.58%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-15.79%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
← Previous
1
2
3
4
5
6
7
8
9
10
11
Next →
Gainers vs Losers
59%
41%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.